基本信息
views: 163
Career Trajectory
Bio
General Area of Research
Immunotherapy is making major progress in the clinic and treatment with checkpoint inhibition (CI) results in significant increase in the overall survival among patients with advanced malignant melanoma. Yet, the majority (>50 %) of patients are not helped, why there is a need for improvements by novel combinations and by predictive biomarkers. Administration of tumor infiltrating lymphocytes (TIL) combined with after low dose chemotherapy has been reported to result in long-lasting clinical responses in 20% of the treated patients in patients with metastatic melanoma.
Immunotherapy is making major progress in the clinic and treatment with checkpoint inhibition (CI) results in significant increase in the overall survival among patients with advanced malignant melanoma. Yet, the majority (>50 %) of patients are not helped, why there is a need for improvements by novel combinations and by predictive biomarkers. Administration of tumor infiltrating lymphocytes (TIL) combined with after low dose chemotherapy has been reported to result in long-lasting clinical responses in 20% of the treated patients in patients with metastatic melanoma.
Research Interests
Papers共 548 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Shi Yong Neo,Le Tong, Joni Chong, Yaxuan Liu,Xu Jing,Mariana M. S. Oliveira,Yi Chen,Ziqing Chen, Keene Lee, Nutsa Burduli,Xinsong Chen,Juan Gao,
Science Translational Medicineno. 747 (2024)
Shi Yong Neo,Le Tong, Joni Chong, Yaxuan Liu,Xu Jing,Mariana M S Oliveira,Yi Chen,Ziqing Chen, Keene Lee, Nutsa Burduli,Xinsong Chen,Juan Gao,
Science translational medicineno. 747 (2024): eadi2952-eadi2952
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn